Patents by Inventor Sung Ah Lee
Sung Ah Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240165171Abstract: A composition for enhancing efficacy of lactic acid bacteria includes at least two branched-chain amino acids selected from the group consisting of leucine, isoleucine and valine. The composition may enhance physiological activity of lactic acid bacteria, for example, the growth promoting efficacy or the intestinal damage inhibitory efficacy of lactic acid bacteria.Type: ApplicationFiled: March 23, 2022Publication date: May 23, 2024Inventors: Won Jae LEE, Eun Kyoung KIM, Sung Hee KIM, Kyung Ah LEE, Bo Ram KIM
-
Publication number: 20240166640Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.Type: ApplicationFiled: January 16, 2024Publication date: May 23, 2024Applicant: Voronoi Inc.Inventors: Youn Ho LEE, Seon Ah Hwang, In Seob Shim, Hyeon Ho Jeon, Woo Mi Do, Hee Sun Ryu, Jung Beom Son, Nam Doo Kim, Sung Hwan Kim, Hong Ryul Jung, Young Yi Lee
-
Patent number: 11991347Abstract: Provided is an image processing device configured to compress first image data. The image processing device includes an encoding circuit configured to compress the first image data into second image data including prediction data and residual data, compress the second image data into third image data by performing entropy encoding on the second image data, generate a header representing a compression ratio of the third image data, and store the third image data along with the header in a memory device as compressed first image data.Type: GrantFiled: July 16, 2021Date of Patent: May 21, 2024Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Sung Ho Jun, Chang Soo Park, Moon Kyu Song, Kyung Koo Lee, Kil Whan Lee, Hyuk Jae Jang, Kyung Ah Jeong
-
Publication number: 20240150331Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.Type: ApplicationFiled: January 16, 2024Publication date: May 9, 2024Applicant: HK INNO.N CORPORATIONInventors: Eun Sun KIM, Min Kyoung LEE, Sung Ah LEE, Kwang Do CHOI, Jae Sun KIM, Hyung Chul YOO
-
Patent number: 11970493Abstract: The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for inhibiting ATX. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.Type: GrantFiled: October 4, 2021Date of Patent: April 30, 2024Assignee: ILDONG PHARMACEUTICAL CO., LTD.Inventors: Sung-Ku Choi, Yoon-Suk Lee, Sung-Wook Kwon, Kyung-Sun Kim, Jeong-Geun Kim, Jeong-Ah Kim, An-Na Moon, Sun-Young Park, Jun-Su Ban, Dong-Keun Song, Kyu-Sic Jang, Ju-Young Jung, Soo-Jin Lee
-
Patent number: 11932618Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.Type: GrantFiled: March 13, 2023Date of Patent: March 19, 2024Assignee: ILDONG PHARMACEUTICAL CO., LTD.Inventors: Hong Chul Yoon, Kyung Mi An, Myong Jae Lee, Jin Hee Lee, Jeong-geun Kim, A-rang Im, Woo Jin Jeon, Jin Ah Jeong, Jaeho Heo, Changhee Hong, Kyeojin Kim, Jung-Eun Park, Te-ik Sohn, Changmok Oh, Da Hae Hong, Sung Wook Kwon, Jung Ho Kim, Jae Eui Shin, Yeongran Yoo, Min Whan Chang, Eun Hye Jang, In-gyu Je, Ji Hye Choi, Gunhee Kim, Yearin Jun
-
Patent number: 11912690Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.Type: GrantFiled: November 21, 2022Date of Patent: February 27, 2024Assignee: HK INNO.N CORPORATIONInventors: Eun Sun Kim, Min Kyoung Lee, Sung Ah Lee, Kwang Do Choi, Jae Sun Kim, Hyung Chul Yoo
-
Patent number: 11912674Abstract: The present invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, which comprises administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.Type: GrantFiled: March 4, 2021Date of Patent: February 27, 2024Assignee: IL DONG PHARMACEUTICAL CO., LTD.Inventors: Jae-Hoon Kang, Hong-Sub Lee, Yoon-Suk Lee, Jin-Ah Jeong, Sung-Wook Kwon, Jeong-Guen Kim, Kyung-Sun Kim, Dong-Keun Song, Sun-Young Park, Kyeo-Jin Kim, Ji-Hye Choi, Hey-Min Hwang
-
Publication number: 20230201164Abstract: The present disclosure relates to a pharmaceutical composition containing a benzimidazole derivative compound. Specifically, the present disclosure relates to a formulation capable of maintaining a sustained blood concentration of the benzimidazole derivative compound.Type: ApplicationFiled: February 26, 2021Publication date: June 29, 2023Inventors: Suchul LEE, Eun Kyung JEON, Young Dae CHO, Sung Ah LEE, Dong Hyun KIM, Myeongjoong KIM, So Hyun JOO, Bong Tae KIM
-
Publication number: 20230192670Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.Type: ApplicationFiled: November 21, 2022Publication date: June 22, 2023Applicant: HK INNO.N CORPORATIONInventors: Eun Sun KIM, Min Kyoung LEE, Sung Ah LEE, Kwang Do CHOI, Jae Sun KIM, Hyung Chul YOO
-
Patent number: 11535610Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.Type: GrantFiled: September 20, 2017Date of Patent: December 27, 2022Assignee: HK INNO.N CORPORATIONInventors: Eun Sun Kim, Min Kyoung Lee, Sung Ah Lee, Kwang Do Choi, Jae Sun Kim, Hyung Chul Yoo
-
Publication number: 20210292307Abstract: The present invention relates to a pidolate salt and malate salt of a compound represented by a formula 1 with an excellent liquid-phase stability, solid-phase stability, water solubility, precipitation stability and hygroscopicity all together as a compound for preventing and treating diseases mediated by an acid pump antagonistic activity, as well as a method for preparing the same.Type: ApplicationFiled: September 20, 2017Publication date: September 23, 2021Applicant: HK INNO.N CORPORATIONInventors: Eun Sun KIM, Min Kyoung LEE, Sung Ah LEE, Kwang Do CHOI, Jae Sun KIM, Hyung Chul YOO
-
Patent number: 10828253Abstract: The present disclosure relates to a composition for injection, which comprises a pharmaceutically acceptable salt of a compound represented by Formula 1 and one or more selected from mannitol, trehalose, lactose and glucose as a stabilizing agent, having improved stability.Type: GrantFiled: July 6, 2018Date of Patent: November 10, 2020Assignee: HK INNO.N CORPORATIONInventors: Hyo Jin Kim, Sung Jun Kim, Min Kyoung Lee, Sung Ah Lee, Mi Young Yoon
-
Publication number: 20200146974Abstract: The present disclosure relates to a composition for injection, which comprises a pharmaceutically acceptable salt of a compound represented by Formula 1 and one or more selected from mannitol, trehalose, lactose and glucose as a stabilizing agent, having improved stability.Type: ApplicationFiled: July 6, 2018Publication date: May 14, 2020Applicant: CJ HEALTHCARE CORPORATIONInventors: Hyo Jin KIM, Sung Jun KIM, Min Kyoung LEE, Sung Ah LEE, Mi Young YOON
-
Patent number: 9908870Abstract: The present invention relates to a novel crystalline form of a benzimidazole derivative and a preparation method thereof. The novel crystalline form according to the present invention is hardly changed chemically and/or physically under a long-term photo-stressed condition, has a low hygroscopicity, and has an extremely low static-electricity-inducing capability, thus being advantageous for formulation, and due to the excellent stability of the crystal form itself, it is very useful for long-term storage of the compound.Type: GrantFiled: November 18, 2015Date of Patent: March 6, 2018Assignee: CJ HEALTHCARE CORPORATIONInventors: Young Ju Kim, Eun Sun Kim, Ji Yun Lee, Hyuk Woo Lee, Jae Hong Kweon, Sung Ah Lee, Kwang Do Choi, Dong Hyun Ko, Seung Pyeong Heo
-
Publication number: 20180009791Abstract: The present invention relates to a novel crystalline form of a benzimidazole derivative and a preparation method thereof. The novel crystalline form according to the present invention is hardly changed chemically and/or physically under a long-term photo-stressed condition, has a low hygroscopicity, and has an extremely low static-electricity-inducing capability, thus being advantageous for formulation, and due to the excellent stability of the crystal form itself, it is very useful for long-term storage of the compound.Type: ApplicationFiled: November 18, 2015Publication date: January 11, 2018Inventors: Young Ju KIM, Eun Sun KIM, Ji Yun LEE, Hyuk Woo LEE, Jae Hong KWEON, Sung Ah LEE, Kwang Do CHOI, Dong Hyun KO, Seung Pyeong HEO
-
Patent number: 9493425Abstract: The present invention provides a method for preparing a compound with a benzimidazole structure with an excellent yield using a low-cost starting material, not requiring an additional separation process, or not using a dangerous reagent during the manufacturing process. Furthermore, the present invention also provides an intermediate and a final product produced by the preparing method.Type: GrantFiled: July 4, 2014Date of Patent: November 15, 2016Assignee: CJ HEALTHCARE CORPORATIONInventors: Jae Hong Kweon, Eun Sun Kim, Seog Beom Song, Sung Ah Lee, Ji Yun Lee, Kwang Do Choi, Young Joon Park
-
Publication number: 20160159747Abstract: The present invention provides a method for preparing a compound with a benzimidazole structure with an excellent yield using a low-cost starting material, not requiring an additional separation process, or not using a dangerous reagent during the manufacturing process. Furthermore, the present invention also provides an intermediate and a final product produced by the preparing method.Type: ApplicationFiled: July 4, 2014Publication date: June 9, 2016Inventors: Jae Hong Kweon, Eun Sn Kim, Seog Beom Song, Sung Ah Lee, Ji Yun Lee, Kwang Do Choi, Young Joon Park
